The development of drotrecogin alfa (activated) for the treatment of severe sepsis

被引：2
|
作者：
Macias, WL [1 ]
Yan, SB [1 ]
Grinnell, BW [1 ]
机构：
[1] Eli Lilly & Co, Lilly Lab Clin Res, Indianapolis, IN 46285 USA
来源：
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS | 2004年 / 27卷 / 05期
关键词：
D O I：
10.1177/039139880402700504
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
[No abstract available]
引用
收藏
页码：360 / 370
页数：11
相关论文
共 50 条
  • [31] Cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in Germany
    Neilson, AR
    Schneider, H
    Chinn, C
    Clouth, J
    Burchardi, H
    [J]. INTENSIVE CARE MEDICINE, 2002, 28 : S161 - S161
  • [32] Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis
    Gordon R Bernard
    William L Macias
    David E Joyce
    Mark D Williams
    Joan Bailey
    Jean-Louis Vincent
    [J]. Critical Care, 7
  • [33] Selecting patients with severe sepsis for drotrecogin alfa (activated) therapy
    Sollet, JP
    Garber, GE
    [J]. AMERICAN JOURNAL OF SURGERY, 2002, 184 (6A): : 11S - 18S
  • [34] Drotrecogin alfa (activated) in severe sepsis after cardiac surgery
    Bubenek, S.
    Stelian, E.
    Craciun, M.
    Miclea, I.
    Sefu, F.
    Boros, C.
    Timofiev, L.
    Tulbure, D.
    [J]. EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2004, 21 : 167 - 168
  • [35] Management of patients with severe sepsis, treated by drotrecogin alfa (activated)
    Laterre, PF
    Heiselman, D
    [J]. AMERICAN JOURNAL OF SURGERY, 2002, 184 (6A): : 39S - 46S
  • [36] Use of drotrecogin alfa (activated) in older patients with severe sepsis
    Alexander, SL
    Ernst, FR
    [J]. PHARMACOTHERAPY, 2006, 26 (04): : 533 - 538
  • [37] Drotrecogin alfa (activated): a novel therapeutic strategy for severe sepsis
    Pastores, SM
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2003, 79 (927) : 5 - 10
  • [38] The safety of drotrecogin alfa (activated) in pediatric patients with severe sepsis
    Goldstein, B
    Williams, M
    Wang, DZ
    Angle, R
    Giroir, B
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (12) : A152 - A152
  • [39] Drotrecogin alfa: a new approach in the treatment of severe sepsis
    Vincent, JL
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2002, 2 (06) : 659 - 664
  • [40] Increased survivorship with drotrecogin alfa (activated) in the treatment of severe sepsis: The effect on hospital costs
    Linde-Zwirble, WT
    Clermont, G
    Van Hout, B
    Ball, DE
    Basson, BR
    Angus, DC
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (12) : A1 - A1
12345